Eqis Capital Management Inc. Sells 1,496 Shares of Relx PLC (NYSE:RELX)

Eqis Capital Management Inc. cut its stake in Relx PLC (NYSE:RELX) by 4.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,742 shares of the technology company’s stock after selling 1,496 shares during the period. Eqis Capital Management Inc.’s holdings in Relx were worth $729,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Vestmark Advisory Solutions Inc. raised its position in shares of Relx by 6.3% during the third quarter. Vestmark Advisory Solutions Inc. now owns 31,737 shares of the technology company’s stock worth $753,000 after purchasing an additional 1,888 shares during the period. Tower Research Capital LLC TRC bought a new position in Relx in the 3rd quarter valued at $38,000. SG Americas Securities LLC grew its stake in Relx by 17.6% in the 3rd quarter. SG Americas Securities LLC now owns 141,924 shares of the technology company’s stock valued at $3,366,000 after purchasing an additional 21,273 shares during the period. Parallel Advisors LLC grew its stake in shares of Relx by 26.0% during the 3rd quarter. Parallel Advisors LLC now owns 4,065 shares of the technology company’s stock worth $96,000 after acquiring an additional 840 shares during the period. Finally, Willingdon Wealth Management grew its stake in shares of Relx by 18.9% during the 3rd quarter. Willingdon Wealth Management now owns 5,919 shares of the technology company’s stock worth $140,000 after acquiring an additional 939 shares during the period. Institutional investors and hedge funds own 2.90% of the company’s stock.

RELX stock opened at $24.29 on Friday. The company has a debt-to-equity ratio of 2.58, a quick ratio of 0.40 and a current ratio of 0.45. The company has a market capitalization of $46.01 billion, a price-to-earnings ratio of 21.50, a PEG ratio of 3.05 and a beta of 0.45. Relx PLC has a fifty-two week low of $19.66 and a fifty-two week high of $24.99. The stock has a fifty day moving average of $23.45 and a 200-day moving average of $23.65.

RELX has been the subject of several research reports. Zacks Investment Research downgraded Relx from a “buy” rating to a “hold” rating in a research note on Thursday, September 26th. ValuEngine upgraded Relx from a “strong sell” rating to a “sell” rating in a research note on Tuesday, October 29th.

Relx Company Profile

RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.

Featured Story: Why Invest in Dividend Achievers?

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx PLC (NYSE:RELX).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.